<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02948660</url>
  </required_header>
  <id_info>
    <org_study_id>81571262</org_study_id>
    <nct_id>NCT02948660</nct_id>
  </id_info>
  <brief_title>The Role of Sleep-modulating Drugs in the Recovery of Patients With Disorders of Consciousness</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <brief_summary>
    <textblock>
      The research contains three parts. Part 1: To explore the evaluating and prognostic values of
      electroencephalography sleep cycle combined with the serum melatonin and orexin level of
      patients with disorders of consciousness; Part 2: To assess the efficacy of the
      wake-promoting function of zolpidem tartrate in comotase patients; Part 3: To assess the
      efficacy of the wake-promoting function of melatonin in comotase patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Coma Recovery Scale-Revised</measure>
    <time_frame>3 months after enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glasgow-Pittsburgh cerebral performance categories</measure>
    <time_frame>3 months after enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Consciousness Disorders</condition>
  <arm_group>
    <arm_group_label>acute consciousness disorders group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Duration time of coma &lt;= 3 weeks.
This group will receive sleep EEG monitoring, serum melatonin and orexin level testing, and Zolpidem Tartrate Tablets or melatonin treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>chronic consciousness disorders group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Duration time of coma &gt; 3 weeks.
This group received sleep EEG monitoring, serum melatonin and orexin testing, and Zolpidem Tartrate Tablets or melatonin treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>zolpidem tartrate</intervention_name>
    <arm_group_label>acute consciousness disorders group</arm_group_label>
    <arm_group_label>chronic consciousness disorders group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>melatonin</intervention_name>
    <arm_group_label>acute consciousness disorders group</arm_group_label>
    <arm_group_label>chronic consciousness disorders group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Glasgow Coma Scale score &lt;=8

          -  vital signs are stable

          -  no history use of sedative or anesthetics

        Exclusion Criteria:

          -  premorbid history of developmental, psychiatric, or neurological illness resulting in
             documented functional disabilities up to time of the injury

          -  severe coexisting systemic disease with a limited life expectancy

          -  EEG showing non-convulsive status epilepticus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wen Jiang, doctor</last_name>
    <role>Study Director</role>
    <affiliation>Department of Neurology, Xijing Hospital, Fourth Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wen Jiang, Doctor</last_name>
    <phone>86-029-84771319</phone>
    <email>jiangwen@fmmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiai Yang, Master</last_name>
    <phone>86-029-84771319</phone>
    <email>yxa2004.7@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurology, Xijing Hospital, Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiai Yang, Master</last_name>
      <phone>+86 029 84771319</phone>
      <email>yxa2004.7@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2016</study_first_submitted>
  <study_first_submitted_qc>October 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2016</study_first_posted>
  <last_update_submitted>November 25, 2016</last_update_submitted>
  <last_update_submitted_qc>November 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Consciousness Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
    <mesh_term>Zolpidem</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

